OPIANT PHARMACEUTICALS INC (OPNT)

US6837501039 - Common Stock

20.65  -0.12 (-0.58%)

After market: 20.75 +0.1 (+0.48%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
22.34M47.79M29.63M40.52M13.98M
Cost Of Goods
3.86M9.07M6.20M7.72M1.49M
Gross Profit
18.47M38.72M23.43M32.80M12.49M
Operating Expenses
49.98M33.56M25.67M21.89M33.68M
Research and Development
25.59M16.83M9.24M9.08M8.48M
Selling, General, and Administrative Expenses
24.39M16.73M16.43M12.81M25.20M
Operating Income
-31.51M5.16M-2.24M10.91M-21.19M
Interest Income/Expense
-1.46M-2.12M-50.00K490.00K100.00K
Non Recurring Items
N/AN/A0.0020.00K-50.00K
Income Before Taxes
-33.02M3.03M-2.29M11.42M-21.14M
Income Tax
65.31K24.27K-430.00K-180.00K50.00K
Net Income
-33.09M3.01M-1.86M11.59M-21.20M
EBITDA
-31.47M5.25M-2.12M10.97MN/A
 
Per Share Data
EPS Diluted Total Ops
-6.560.51-0.442.17-7.10
Non GAAP EPS
-6.550.32-0.462.04N/A
 
Statistics
Gross Profit Margin
82.70%81.03%79.08%80.95%89.34%
Profit Margin
-148.12%6.30%-6.28%28.60%-151.65%
Operating Profit Margin
-141.05%10.79%-7.56%26.92%-151.57%

All data in USD

Charts